Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Neurology Gastroenterology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

1011 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

1011 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase III Oncology
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer…
07 Apr 2026 NCT06875310
● Recruiting Phase I Oncology
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study of Sigvotatug Vedotin in Advanced Solid Tumors is Recruiting • Phase I • Oncology • NCT04389632. This trial will look at a…
07 Apr 2026 NCT04389632
● Recruiting Phase I Oncology
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors is Recruiting • Phase I • Oncology •…
07 Apr 2026 NCT07090499
● Recruiting Phase III Oncology
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell…
07 Apr 2026 NCT06758401
● Recruiting Phase III Oncology
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors is Recruiting • Phase III • Oncology…
07 Apr 2026 NCT03067181
● Recruiting Phase III Oncology
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive…
07 Apr 2026 NCT07144280
● Recruiting Phase III Rheumatology
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines is Recruiting • Phase III…
06 Apr 2026 NCT06671496
● Recruiting
Patient Retrospective Outcomes (PRO)
Patient Retrospective Outcomes (PRO) is Recruiting • Phase not applicable • NCT01550575. Review the linked registry entry for study design, population, endpoints, and operational…
06 Apr 2026 NCT01550575
active not recruiting Cardiology / Cardiovascular
A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development
A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development is…
06 Apr 2026 NCT06055725
● Recruiting Diabetes / Metabolic
Safety and Effectiveness of Orbera365™ Intragastric Balloon System
Safety and Effectiveness of Orbera365™ Intragastric Balloon System is Recruiting • Phase not applicable • Diabetes / Metabolic • NCT07062094. Review the linked registry…
06 Apr 2026 NCT07062094
● Recruiting Phase II Neurology
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults is Recruiting • Phase II • Neurology • NCT06937931. Review the linked…
06 Apr 2026 NCT06937931
active not recruiting Phase III Oncology
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients is Active Not Recruiting • Phase III • Oncology • NCT03049189. Review the linked registry…
06 Apr 2026 NCT03049189
active not recruiting Phase III
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults is Active Not Recruiting • Phase…
06 Apr 2026 NCT06047444
● Recruiting Phase III Dermatology
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With…
06 Apr 2026 NCT06241118
● Recruiting Phase III Oncology
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer is Recruiting • Phase III • Oncology •…
06 Apr 2026 NCT07228832
● Recruiting Phase I Oncology
A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha
A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha is Recruiting • Phase I • Oncology • NCT06547840.…
06 Apr 2026 NCT06547840
● Recruiting Phase IV Oncology
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies is Recruiting • Phase IV • Oncology • NCT06274515. This study will evaluate…
06 Apr 2026 NCT06274515
● Recruiting Phase I Oncology
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer is Recruiting • Phase I • Oncology • NCT05386108.…
06 Apr 2026 NCT05386108
● Recruiting Neurology
Trial-Ready Cohort-Down Syndrome (TRC-DS)
Trial-Ready Cohort-Down Syndrome (TRC-DS) is Recruiting • Phase not applicable • Neurology • NCT04165109. The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS)…
06 Apr 2026 NCT04165109
● Recruiting Phase III Neurology
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson’s Disease
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson’s Disease is Recruiting • Phase III •…
06 Apr 2026 NCT07174310
● Recruiting Neurology
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System – RAPID for CNS
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System – RAPID for CNS is Recruiting • Phase not applicable • Neurology • NCT06553625.…
06 Apr 2026 NCT06553625
● Recruiting Phase III Rheumatology
Crohn’s Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn’s Disease
Crohn’s Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn’s Disease is Recruiting • Phase III •…
06 Apr 2026 NCT06332534
● Recruiting Phase II Cardiology / Cardiovascular
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008) is Recruiting • Phase II • Cardiology / Cardiovascular • NCT05587712.…
06 Apr 2026 NCT05587712
● Recruiting Phase II Respiratory / COPD / Asthma
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) is Recruiting • Phase II • Respiratory / COPD / Asthma…
06 Apr 2026 NCT07116031
● Recruiting Respiratory / COPD / Asthma
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung – Study 3
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung – Study 3 is Recruiting • Phase not applicable • Respiratory / COPD / Asthma…
06 Apr 2026 NCT06891755
● Recruiting Oncology
Lung cAncer Robotic Comparative Study
Lung cAncer Robotic Comparative Study is Recruiting • Phase not applicable • Oncology • NCT06038227. To compare outcomes of minimally invasive surgical techniques for…
06 Apr 2026 NCT06038227
● Recruiting Phase III Oncology
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated…
06 Apr 2026 NCT04928846
● Recruiting Cardiology / Cardiovascular
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure is Recruiting • Phase not applicable • Cardiology / Cardiovascular •…
06 Apr 2026 NCT06557798
● Recruiting Phase II Cardiology / Cardiovascular
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes is Recruiting • Phase II • Cardiology / Cardiovascular • NCT06435156. People with…
06 Apr 2026 NCT06435156
● Recruiting Phase II Oncology
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) is Recruiting • Phase II • Oncology • NCT06833073.…
06 Apr 2026 NCT06833073
● Recruiting Phase I Oncology
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer is Recruiting • Phase I • Oncology • NCT04360941. This clinical study is…
06 Apr 2026 NCT04360941
● Recruiting Phase I Oncology
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors is Recruiting • Phase…
06 Apr 2026 NCT04774718
● Recruiting Oncology
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test is Recruiting • Phase not applicable • Oncology • NCT04529122. WAYFIND-R is…
06 Apr 2026 NCT04529122
● Recruiting Phase I Oncology
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia is Recruiting • Phase I • Oncology •…
06 Apr 2026 NCT07109219
● Recruiting Phase II Oncology
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis is Recruiting • Phase II • Oncology…
06 Apr 2026 NCT04910685
● Recruiting Phase II Oncology
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)…
03 Apr 2026 NCT06534983
● Recruiting Phase III
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps…
03 Apr 2026 NCT06834347
active not recruiting Phase III Rare Diseases
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia…
03 Apr 2026 NCT03861273
● Recruiting Phase II
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab is Recruiting…
03 Apr 2026 NCT07039422
active not recruiting Phase I / Phase II Oncology
A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.
A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers. is Active Not…
03 Apr 2026 NCT06116136
active not recruiting Phase I
A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234 is Active Not Recruiting • Phase I • NCT07220954. Review the linked…
03 Apr 2026 NCT07220954
● Recruiting Phase III
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation is Recruiting •…
03 Apr 2026 NCT06465953
● Recruiting Phase III Oncology
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents is Recruiting • Phase III • Oncology…
03 Apr 2026 NCT06120491
● Recruiting Phase III Oncology
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. is Recruiting • Phase III • Oncology • NCT06382948.…
03 Apr 2026 NCT06382948
● Recruiting Phase III Respiratory / COPD / Asthma
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease is Recruiting • Phase III • Respiratory / COPD / Asthma • NCT07169578.…
03 Apr 2026 NCT07169578
● Recruiting Phase I Neurology
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer’s Disease (eAD)
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer’s Disease (eAD) is Recruiting • Phase…
03 Apr 2026 NCT07234942
● Recruiting Phase I Oncology
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer is Recruiting…
03 Apr 2026 NCT06764316
● Recruiting Phase III Gastroenterology
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH is Recruiting • Phase III •…
03 Apr 2026 NCT06419374
● Recruiting Phase II Rheumatology
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety…
03 Apr 2026 NCT05039619
● Recruiting Phase II Mental Health / Psychiatry
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease is Recruiting • Phase II •…
03 Apr 2026 NCT07355296